LA JOLLA, Calif. -- Although their genetic underpinnings differ, Alzheimer's disease, Parkinson's disease and Huntington's disease are all characterized by the untimely death of brain cellsWhat triggers cell death in the brain? According to a new study published by researchers at Sanford-Burnham M

read more>>

ST. PAUL, Minn. -- A new study shows that a sleep disorder may be a sign of dementia or Parkinson's disease up to 50 years before the disorders are diagnosedThe research is published in the July 28, 2010, online issue of Neurology®, the medical journal of the American Academy of NeurologyUsin

read more>>

STANFORD, Calif. -- Scientists at the Stanford University School of Medicine have identified a molecular pathway responsible for the death of key nerve cells whose loss causes Parkinson's diseaseThis discovery not only may explain how a genetic mutation linked to Parkinson's causes the cells' deat

read more>>

EAST LANSING, Mich. -- A Michigan State University researcher is working to uncover how a protein known as parkin may help nerve cells fight off damage from Parkinson's disease, a strategy that could lead to new therapies for the degenerative ailmentJohn Goudreau, an osteopathic physician and dire

read more>>

Vernalis plc (LSE: VER), a leading development stage pharmaceutical company with a broad pipeline of clinical and early stage programmes, today announced that the company and its partner, Biogen Idec (NASDAQ: BIIB), will continue its novel A2A receptor antagonist programme for Parkinson’s Ba

read more>>

A group of researchers from Universidad Carlos III de Madrid (UC3M) has presented a new algorithm that uses a new method to analyse the information obtained from electroencephalograms to detect neurodegenerative diseases, such as epilepsy, using the bioelectric signals of the brainThe research pro

read more>>

NEW YORK -- The Michael J. Fox Foundation has committed up to $12 million in 2011 funding for prioritized research toward transformative treatments and a cure for Parkinson's diseaseFunding is open to academic and industry researchers through the Foundation's Pipeline Programs, which consist of th

read more>>

NEW YORK -- The Michael J. Fox Foundation announced a lead gift of $2.5 million from philanthropist Lily Safra to support the Parkinson's Progression Markers Initiative (PPMIMrs. Safra's commitment will help galvanize the search for a biomarker of Parkinson's disease progressionPPMI is a landmar

read more>>

Many of the symptoms of Parkinson disease can be alleviated with drugs that target dompamine, a chemical in the brain that is involved in nerve cell communication and therefore known as a neurotransmitterHowever, such drugs do not improve the gait disorders and falls that commonly affect individua

read more>>

A new study on vitamin D levels and Parkinson's disease risk points to the need for further research on whether vitamin D supplements can protect against the movement disorder, according to an editorial in the July 2010 issue of Archives of NeurologyThe author of the editorial is Marian Evatt, MD,

read more>>